SMAD3 and chronic kidney disease: The incidence of acute kidney injury (AKI) and chronic kidney disease (CKD) is reduced in mice lacking Smad3, suggesting that genetic deletion or pharmacological inhibition of Smad3 may help reduce kidney damage in mouse models of ischemia-induced kidney disease [44].